Reaction Details Report a problem with these data
Target
Protease
Ligand
BDBM50479982
Substrate
n/a
Meas. Tech.
ChEMBL_544292 (CHEMBL1020430)
Ki
0.008±n/a nM
Citation
 Hazen, R; Harvey, R; Ferris, R; Craig, C; Yates, P; Griffin, P; Miller, J; Kaldor, I; Ray, J; Samano, V; Furfine, E; Spaltenstein, A; Hale, M; Tung, R; St Clair, M; Hanlon, M; Boone, L In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV. Antimicrob Agents Chemother 51:3147-54 (2007) [PubMed]  Article 
Target
Name:
Protease
Synonyms:
n/a
Type:
Enzyme
Mol. Mass.:
10904.79
Organism:
Human immunodeficiency virus 1 (HIV-1)
Description:
Q9YQ12
Residue:
99
Sequence:
PQITLWQRPFVTIKIEGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQIVIEICGKKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
  
Inhibitor
Name:
BDBM50479982
Synonyms:
Aptivus | CHEBI:63628 | Tipranavir | U-140690 | US10806794, Compound Tipranavir
Type:
Small organic molecule
Emp. Form.:
C31H33F3N2O5S
Mol. Mass.:
602.664
SMILES:
CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(cn3)C(F)(F)F)c2)C(=O)O1 |t:15|
Structure:
Search PDB for entries with ligand similarity: